Hanover lands brief to raise UCB's profile in the UK

Hanover has been brought in to promote biopharma company UCB to the UK's world-leading life sciences market.

Life sciences: Hanover will boost UK’s image as a place to invest
Life sciences: Hanover will boost UK’s image as a place to invest

The agency has been handed a public affairs and corporate comms brief aimed at raising the profile of the company and strengthening the UK’s image as favourable for life-science investment.

The UK life science industry has more than 4,000 companies employing a total of about 160,000 staff. The sector’s annual turnover is more than £50bn.

Hanover’s head of healthcare Andrew Harrison said: ‘The UK has always been a good place for research and development. But over the past ten to 20 years, other countries have been working hard to catch up, and this appointment is about ensuring the UK retains its status.’

He added: ‘UCB is one of the top five life science research and development investors in the UK and has a huge amount to offer patients, the NHS and this country’s economic growth agenda.’

The six-figure, two-year retained account will be led by Harrison. Hanover will report to UCB’s director of government affairs Gordon Lundie and head of comms Scott Fleming.

Lundie said: ‘Throughout the pitch process the team showed a real passion and enthusiasm for our work and their health expertise in both London and Brussels gave them a competitive advantage.’

The Belgian company spent more than £230m on R&D in 2010. It focuses on central nervous system disorders, such as Parkinson’s disease and epilepsy, and immunology diseases. Last year, UCB retained Fleishman-Hillard to provide global PR support for rheumatoid arthritis treatment Cimzia. The agency was reappointed following a four-way pitch.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.

Former White House press secretary Dee Dee Myers to join Warner Bros

Former White House press secretary Dee Dee Myers to join Warner Bros

Warner Bros has appointed former White House press secretary Dee Dee Myers as EVP for worldwide corporate communications and public affairs, effective September 2.